Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Debt / NOTE 4.000% 2/0
-
Market price (% of par)
-
97.14%
-
Total 13F principal
-
$198,571,465
-
Principal change
-
-$15,982,554
-
Total reported market value
-
$208,034,013
-
Number of holders
-
29
-
Value change
-
-$2,984,215,131
-
Number of buys
-
5
-
Number of sells
-
11
Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 as of Q3 2016
As of 30 Sep 2016,
PDL BIOPHARMA INC - NOTE 4.000% 2/0 was held by
29 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$198,571,465
in principal (par value) of the bond.
The largest 10 bondholders included
ASCEND CAPITAL, LLC, UBS ASSET MANAGEMENT AMERICAS INC, Whitebox Advisors LLC, CNH PARTNERS LLC, PIONEER INVESTMENT MANAGEMENT INC, LAZARD ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, Park West Asset Management LLC, WOLVERINE ASSET MANAGEMENT LLC, and Context Capital Management, LLC.
This page lists
29
institutional bondholders reporting positions
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.